The chaos continued when Vinay Prasad — fired last year and rehired less than two weeks later — was announced to be departing ...
With a focus on increasing public safety and reducing the availability of illegal drugs in tribal communities, the Washington ...
The FDA is doubling down on its goal to increase biosimilar drug availability in the U.S. with a fresh draft guidance proposing more changes to streamline development of the cheaper biologic copies.
In a recently published review, a research team led by MedUni Vienna has highlighted a promising new approach to drug discovery. The focus is on the targeted modulation of certain intracellular ...
Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. Dr. Marty Makary, commissioner of the Food and ...
Food and Drug Administration Commissioner Marty Makary warned that the U.S. is falling behind China in early-stage drug development and called for reforms that could streamline the process for ...
As AI drug discovery enters 2026, the industry faces a pivotal year of clinical tests, regulatory clarity, and market consolidation. Here, Dr Raminderpal Singh examines where AI is delivering ...
Development of new osteoporosis medications holds much promise. Safer osteoporosis drugs (devoid of adverse side-effects) would go a long way to rebuild patient confidence and avoid treatment inertia.
Replacing a hydrogen atom in the drug with a boron-fluorine compound, boracycle, opens up great opportunities to modify the drug's properties. In this illustration, the boron-fluorine compound has ...
2026 is set to be a pivotal year for drug discovery, with advances in NAMs and evolving regulatory approaches promising faster, safer early drug development and accelerated delivery of therapies for ...
An experimental drug called NU-9 has shown promise as an early intervention for Alzheimer’s disease. The corresponding study was published in Alzheimer’s & Dementia. "Alzheimer's disease begins ...
IQVIA Holdings is positioned as the indispensable data and technology backbone of the life sciences industry, far beyond a traditional CRO. Long-term revenue visibility is underpinned by a record ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results